Jinhua Central Hospital

Jinhua 321000

1 studies enrolling now · 2 studies all time

What they study most

HER2-amplified Biliary Tract Cancers, Metabolic Dysfunction-Associated Steatotic Liver Disease

Studies at this site

• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers — Completed